The Office of New Drugs is undergoing a reorganization. This site may be updated in the near future. Please check back often. For more information, please visit Reorganization of the Office of New Drugs with Corresponding Changes to the Office of Translational Sciences and the Office of Pharmaceutical Quality.
The Division of Hematology Oncology Toxicology reviews nonclinical pharmacology and toxicology aspects of cancer therapies in support of INDs, NDA, and BLAs.
Director: John Leighton, Ph.D.
Deputy Division Director: Haleh Saber
Food and Drug Administration
Center for Drug Evaluation and Research
Division of Hematology Oncology Toxicology
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-7550
Fax: (301) 796-9845